European Association of Nuclear Medicine

European Association of Nuclear Medicine
AbbreviationEANM
FormationSeptember 6, 1985 (1985-09-06)
TypeNon-profit organisation, scientific society
HeadquartersVienna, Austria
Official language
English
Websiteeanm.org

The European Association of Nuclear Medicine (EANM) is the leading professional organisation for nuclear medicine in Europe. Established in 1985, the EANM serves as an umbrella organisation comprising national societies, affiliated societies and individual members working in nuclear medicine or related fields. It is also dedicated to the promotion of nuclear medicine amongst international organisations like the International Atomic Energy Agency, EU institutions like the European Union and the general public.[1]

The EANM also obtained international recognition for its annual congress, which gathers over 7,000 participants every year, and for its ESMIT teaching programme, launched in 2015 in Vienna, Austria. Additionally, the EANM has its own monthly peer-reviewed medical journal, the European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI).[2]

History

The EANM was founded in 1985 in London, United Kingdom following the union of the Society of Nuclear Medicine Europe and the European Nuclear Medicine Society.[3]

The first EANM Congress took place in 1988 in Milan, Italy.[4] Since then, the EANM Annual Conference has been taking place in multiples countries, including Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Portugal, Scotland, Spain, Sweden, Switzerland, The Netherlands, Turkey, and the United Kingdom.[5]

The headquarters are based in Vienna, Austria. The EANM is also represented in Brussels, Belgium, where the organisation closely works with the European Commission and partner organisations.[6]

Structure

The EANM is governed by an elected Board of international experts in nuclear medicine. The Board serves as the top executive body of the organisation. The elected Presidents, who serve a two-year mandate and represent the organisation, are supported by their team to expand the EANM’s outreach.[7]

Nuclear medicine being used in many medical disciplines, the EANM’s volunteers are divided into Committees, which focus on promoting nuclear medicine in different areas, including:[8]

    • Bone and joint
    • Cardiovascular
    • Dosimetry
    • Ethics
    • Inflammation & infection
    • Neuroimaging
    • Oncology & Theranostics
    • Paediatrics
    • Physics
    • Policy & regulatory affairs
    • Radiation protection
    • Radiopharmaceutical sciences
    • Technologists
    • Thyroid
    • Molecular imaging & therapy

    The Executive Office, based in Vienna, oversees all the logistical aspects, ranging from organising scientific events, to managing publications and establishing new partnerships, and promoting the organisation among EU institutions. The Executive Office also organises the Annual Congress and managed the ESMIT courses.[9]

    Membership-wise, the EANM currently comprises 40 national societies, 20 non-European affiliated societies and 2,900 individual members from 80 countries from Europe and beyond. The EANM is also supported by a team of over 150 volunteers, who work within the Board and the Committees.[10]

    Activities

    Annual Congress

    EANM'16 in Barcelona, Spain

    The EANM Annual Congress features scientific sessions, workshops, and interactive discussions led by speakers.[11] It brings together international experts and professionals in the field of nuclear medicine to discuss the latest advancements and innovations in nuclear medicine and molecular imaging.[12]

    EU Affairs

    The EANM closely works with EU institutions and EU policymakers to shed more light on the properties of nuclear medicine and to ensure that EU citizens have access to high-quality and safe therapeutic nuclear medicine.[13]

    For instance, as part of the European Commission’s SAMIRA Action Plan, the EANM is part of the consortium performing the SIMPLERAD Project, which seeks to ensure that Euratom radiation protection requirements and the EU legislation concerning the therapeutic use of radiopharmaceuticals are implemented.[14]

    Publications


    The EANM’s official journal is the European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI).

    The EJNMMI serves as a platform for the dissemination of research and advancements in the field of nuclear medicine and molecular imaging. It publishes original articles, reviews, case reports, and guidelines that cover various aspects of nuclear medicine, radiopharmaceuticals, imaging techniques, and their clinical applications.[15]

    ESMIT

    ESMIT's official logo

    The EANM is highly active in the field of education. Its European School of Multimodality Imaging & Therapy (ESMIT) was founded in 2015 as a response to the rising demand for educational programmes focusing on nuclear medicine.[16]

    The EANM launched ESMIT to equip health professionals with knowledge about both the modalities of nuclear medicine and its therapeutic applications. With the help of experienced faculty members, the EANM thus offers a wide range of learning experiences, ranging from in-person advanced courses, to live webinars and an eLearning platform.[17]

    EARL

    The EANM established EANM Forschungs GmbH, also known as EANM Research Ltd. (EARL), in 2006 to promote standardised quantification in nuclear medicine imaging.[18] As a subsidiary of the EANM, EARL's primary goal is to enhance nuclear medicine practice, drive scientific initiatives, and facilitate clinical research projects.[19]

    References

    1. ↑ "IAEA Director General at EANM Annual Congress: Nuclear Medicine is Key for Global Health". International Atomic Energy Agency. International Atomic Energy Agency News. 23 October 2017. Retrieved May 26, 2023.
    2. ↑ "What is the European Journal of Nuclear Medicine and Molecular Imaging?". May 26, 2023. Retrieved May 26, 2023.
    3. ↑ Ell, Peter J. (November 1996). "Nuclear Medicine Organizations in Europe" (PDF). The Journal of Nuclear Medicine. 37 (11): 26–31. PMID 8917166. Retrieved May 26, 2023.
    4. ↑ "European Nuclear Medicine Congress 1985. London, 3-6 September 1985. Abstracts". Nuc Med Commun. 535 (9): 611. 1985. PMID 3877893. Retrieved May 26, 2023.
    5. ↑ "EANM Past Congresses". EANM. 8 November 2016. Retrieved May 26, 2023.
    6. ↑ De Rimini, Maria Luisa. "European Association of Nuclear Medicine - EANM" (PDF). Seguici Events. UOC Medicina Nucleare, AORN Ospedali dei Colli, Napoli. Retrieved May 26, 2023.
    7. ↑ "Erba prepares to become president elect of EANM". AuntMinnieEurope.com. Retrieved May 26, 2023.
    8. ↑ M. Lassmann & L. Biassoni & M. Monsieurs & C. Franzius & F. Jacobs & (4 April 2007). "The new EANM paediatric dosage card" (PDF). Eur J Nucl Med Mol Imaging. 34 (1): 796–798. doi:10.1007/s00259-007-0370-0. PMID 17406866. S2CID 32939710.
    9. ↑ "EANM Executive Office". EANM. 31 October 2016. Retrieved May 26, 2023.
    10. ↑ "General Information". European Association of Nuclear Medicine. Retrieved June 26, 2023.
    11. ↑ "Diagnostics and therapy in prostate cancer were hot topics at EANM meeting". Rad Magazine. November 11, 2019. Retrieved May 26, 2023.
    12. ↑ Matassa, Giovanni; Gelardi, Fabrizia; Hustinx, Roland; Chiti, Arturo (April 28, 2021). "Highlights of 33rd EANM Annual Congress 2020, virtual edition". European Journal of Nuclear Medicine and Molecular Imaging. 48 (8): 2314–2318. doi:10.1007/s00259-021-05366-4. PMC 8079516. PMID 33909087.
    13. ↑ "Research 4 Life". Simplerad. Retrieved May 31, 2023.
    14. ↑ "SAMIRA Action Plan". European Commission.
    15. ↑ "About". European Journal of Nuclear Medicine and Molecular Imaging. Retrieved May 31, 2023.
    16. ↑ "New Initiative: The European School of Multimodality Imaging and Therapy". SSNM. Retrieved May 26, 2023.
    17. ↑ "ESMIT Online Education". EANM. 3 November 2016. Retrieved May 26, 2023.
    18. ↑ "Welcome". Research 4 Life. Retrieved May 26, 2023.
    19. ↑ Andres Kaalep, Terez Sera, Wim Oyen, Bernd J. Krause, Arturo Chiti, Yan Liu, and Ronald Boellaard (2018). "EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems". Eur J Nucl Med Mol Imaging. 45 (3): 412–422. doi:10.1007/s00259-017-3853-7. PMC 5787222. PMID 29192365.{{cite journal}}: CS1 maint: multiple names: authors list (link)
    This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.